https://www.gmo.com/americas/research-library/american-unexceptionalism_gmoquarterlyletter/While it may sound like continued data to defend their decades long sluggish performance because of over emphasis on Emerging Markets and International stocks, they have some very interesting data about comparisons of growth rates between US and international equities.
A lot of US results are due to the Dollar and increasing valuations. If both of these are as high as they can go and due to fall it will not be positive for US equities
Comments
signed person who overweights EM in his international allocation and has for 7 years.
if one covers enough grantham material, it is clear that his experience prioritizes survival\defense over timing bubbles.
he has long since abandoned AUM as any kind of marker for his strategy; GMO is far above the minimum needed for a firm its size to continue.
Hussman and Arnott have been wrong for as long.
These people forgot that markets collapse many times based on special conditions/situations.
2008-MBS
2018-Fed raised rates 3-4 times within a year.
2020-Covid
2022-Inflation made the Fed raise rates very rapidly.
Valuation models aren’t gospel. They’re frameworks, often rigid ones. Markets don’t “obey” a PE ratio, a CAPE model, or any single metric. They move based on flows, positioning, liquidity, sentiment, and risk appetite — none of which those “experts” fully capture.
Articulation ≠ expertise. Some people build reputations on talking smoothly on CNBC or writing clever papers. But if you look under the hood, their track records are mediocre or not disclosed at all. A true expert has numbers behind them, not just words.
Macro talk rarely drives short-term results. Tariffs, inflation debates, and political narratives — they sound convincing, but the link between those stories and stock prices in the next 1–12 months is weak. Liquidity and momentum can swamp those factors.
The real experts are rare. They don’t talk much because they’re too busy managing money. They know the limits of prediction and don’t oversell their opinions.
So, how can anyone listen or invest with these guys?
The long-term performance for GMO Quality Fund - Class III (GQETX) has been very good.
https://testfol.io/?s=4SKuOpC7IR2
GMO offers a newer ETF (QLTY) which follows the same strategy but omits foreign stocks.